IRB Oversight: HHS’ Registration Practices, Firms Conduct To Face Greater Scrutiny
This article was originally published in The Pink Sheet Daily
Executive Summary
Hearing in House may boost prospects of legislation that would impose new requirements on the initial approval of clinical trials.